Trial Profile
A Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 19 Jul 2013 Planned end date changed from 1 Dec 2011 to 1 Dec 2014 as reported by ClinicalTrials.gov record.
- 18 Nov 2011 Planned End Date changed from 1 Feb 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 03 Feb 2010 New trial record